Auto-Immune Disease Diagnostics for Animal refers to the process of diagnosing autoimmune diseases in animals. Autoimmune diseases occur when the immune system mistakenly attacks and damages the body's own tissues and organs.

The global Auto-Immune Disease Diagnostics for Animal market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime's newest research report, the “Auto-Immune Disease Diagnostics for Animal Industry Forecast” looks at past sales and reviews total world Auto-Immune Disease Diagnostics for Animal sales in 2022, providing a comprehensive analysis by region and market sector of projected Auto-Immune Disease Diagnostics for Animal sales for 2023 through 2029. With Auto-Immune Disease Diagnostics for Animal sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Auto-Immune Disease Diagnostics for Animal industry.

This Insight Report provides a comprehensive analysis of the global Auto-Immune Disease Diagnostics for Animal landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Auto-Immune Disease Diagnostics for Animal portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Auto-Immune Disease Diagnostics for Animal market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Auto-Immune Disease Diagnostics for Animal and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Auto-Immune Disease Diagnostics for Animal.

United States market for Auto-Immune Disease Diagnostics for Animal is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Auto-Immune Disease Diagnostics for Animal is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Auto-Immune Disease Diagnostics for Animal is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Auto-Immune Disease Diagnostics for Animal players cover IDEXX Laboratories, ABAXIS, Heska Corporation, Accuplex Diagnostics, Neogen Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Auto-Immune Disease Diagnostics for Animal market by product type, application, key players and key regions and countries.

• Test
• Indication

• Hospitals
• Clinic

This report also splits the market by region:

• United States
• Canada
• Mexico
• Brazil

• China
• Japan
• Korea
• Southeast Asia
• India
• Australia

• Germany
• France
• UK
• Italy
• Russia

• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• IDEXX Laboratories
• ABAXIS
• Heska Corporation
• Accuplex Diagnostics
• Neogen Corporation
• Mindray Medical International Ltd
• Agfa Healthcare
• Elabscience Biotechnology Co. Ltd.
• VCA, Inc.
• Zoetis, Inc.
• ID Vet
• Thermo Fisher Scientific
• GE Healthcare